Today, one of the largest cannabis companies in the world began trading on the New York Stock Exchange.
Under the stock ticker ACB, Aurora began the day down almost 12%. Not a great debut, especially after losing a whopping 22% last week as the company got ready to finally list on the American exchange.
Based in Canada, Aurora has been trading on the Toronto Stock Exchange (TSX) under the symbol ACB since July 24th of this year.
Aurora now joins its fellow Canadian cannabis producers, Tilray (TLRY), Canopy Growth (CGC), and Cronos Group (CRON), all who have recently listed their companies on U.S. based markets.
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR").
The company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as "Aurora Sky", at the Edmonton International Airport, and has acquired, and is undertaking completion of, a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal's West Island.
In addition, the company is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis, as well as owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union ("EU"), based in Germany, Aurora's common shares now trade on TSX under the symbol "ACB" - Terry Booth, CEO, Aurora Cannabis